Received May 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
mild headache for about five hours; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced headache (Verbatim: mild headache for about five hours). The outcome of the headache was resolved (duration 5 hrs). It was unknown if the reporter considered the headache to be related to Shingles vaccine. It was unknown if the company considered the headache to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 30-APR-2025 The case was received from the patient via interactive digital media. The reporter got his/her a few years back. Only side affect he/she had was a very mild headache for about five hours. Much better than getting shingles's.